日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia.

STAT3 和 STAT5 反应异常低与儿童急性髓系白血病的不良预后和炎症基因表达特征相关

Narayanan P, Man T-K, Gerbing R B, Ries R, Stevens A M, Wang Y-C, Long X, Gamis A S, Cooper T, Meshinchi S, Alonzo T A, Redell M S

Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children's Oncology Group

TET2 SNP rs2454206 的种族变异及其与儿童急性髓系白血病临床结局的关联:来自儿童肿瘤协作组的报告

Kutny, M A; Alonzo, T A; Gamazon, E R; Gerbing, R B; Geraghty, D; Lange, B; Heerema, N A; Sung, L; Aplenc, R; Franklin, J; Raimondi, S C; Hirsch, B A; Konkashbaev, A; Cox, N J; Onel, K; Gamis, A S; Meshinchi, S

Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group

将美国国家癌症研究所资助的合作肿瘤组数据与行政数据源合并,以开发更有效的临床试验分析和比较疗效研究平台:儿童肿瘤协作组的报告

Aplenc, R; Fisher, B T; Huang, Y S; Li, Y; Alonzo, T A; Gerbing, R B; Hall, M; Bertoch, D; Keren, R; Seif, A E; Sung, L; Adamson, P C; Gamis, A

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study

急性髓系白血病中IDH1基因的分子改变:儿童肿瘤协作组和西南肿瘤协作组的研究

Ho, P A; Alonzo, T A; Kopecky, K J; Miller, K L; Kuhn, J; Zeng, R; Gerbing, R B; Raimondi, S C; Hirsch, B A; Oehler, V; Hurwitz, C A; Franklin, J L; Gamis, A S; Petersdorf, S H; Anderson, J E; Reaman, G H; Baker, L H; Willman, C L; Bernstein, I D; Radich, J P; Appelbaum, F R; Stirewalt, D L; Meshinchi, S

DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group

DNA修复多态性与急性髓系白血病化疗疗效:儿童肿瘤协作组报告

Bhatla, D; Gerbing, R B; Alonzo, T A; Mehta, P A; Deal, K; Elliott, J; Meshinchi, S; Geiger, H; Perentesis, J P; Lange, B J; Davies, S M